Abnormal renal resistive index in patients with mild-to-moderate chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue 2, 2013, Pages 216-225

  Chen, Cheng Yu ^a,b   Hsu, Ta Wei ^a   Mao, Simon J T ^c   Chang, Shih Chieh ^a   Yang, Pan Chyr ^d   Lee, Yu Chin ^a,e   Yang, Kuang Yao ^a,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CARDINAL TIEN COLLEGE OF HEALTHCARE AND MANAGEMENT   (Taiwan)

^c NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cigarette smoking; COPD; Doppler ultrasonography; Renal insufficiency; Renal vascular resistance

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; KIDNEY VASCULAR RESISTANCE; LUNG FUNCTION; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESISTIVE INDEX; SMOKING;

AGE FACTORS; AGED; AGED, 80 AND OVER; FORCED EXPIRATORY VOLUME; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONOGRAPHY, DOPPLER; VASCULAR RESISTANCE; VASCULAR STIFFNESS;

EID: 84875872725     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.719051     Document Type: Article

References (53)

1. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291(7):844-850.
2. Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V. Chronic renal failure: a neglected comorbidity of COPD. Chest 2010; 137(4):831-837.
3. van Gestel YR, Chonchol M, Hoeks SE, Welten GM, Stam H, Mertens FW, van Domburg RT, Poldermans D. Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrology, Dialysis, Transplantation: Official publication of the European Dialysis and Transplant Association -European Renal Association 2009; 24(9):2763-2767.
4. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370(9589):797-799
5. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107(11):1514-1519.
6. Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, Kohansal R, Burghuber OC. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2008; 178(12):1211-1218.
7. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, Wilkinson IB, Cockcroft JR, Shale DJ. Arterial stiff ness and osteoporosis in chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2007; 175(12):1259-1265.
8. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107(1):87-92.
9. Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Amer J Kidney Dis: Off J Natl Kidney Foun 2009; 53(4):596-605.
10. Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, Loukides S. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 2007; 132(1):164-169.
11. Bosch JP, Lew S, Glabman S, Lauer A. Renal hemodynamic changes in humans. Response to protein loading in normal and diseased kidneys. Amer J Med 1986; 81(5):809-815.
12. Kawai T, Kamide K, Onishi M, Yamamoto-Hanasaki H, Baba Y, Hongyo K, Shimaoka I, Tatara Y, Takeya Y, Ohishi M, et al. Usefulness of the resistive index in renal Doppler ultrasonography as an indicator of vascular damage in patients with risks of atherosclerosis. Nephrology, Dialysis, Transplantation: Official publication of the European Dialysis and Transplant Association -European Renal Association 2011; 26(10):3256-3262.
13. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H. Use of Doppler ultrasonography to predict the outcome of therapy for renalartery stenosis. New Engl J Med 2001; 344(6):410-417.
14. Jansen O, Rob PM, Schmidtke V, Marienhoff N, Rinast E, Weiss HD. Follow-up study of renal transplants by duplex Doppler and gray-scale ultrasound. Euro J Radiol 1992; 15(1):26-31.
15. Kirkpantur A, Yilmaz R, Baydar DE, Aki T, Cil B, Arici M, Altun B, Erdem Y, Erkan I, Bakkaloglu M et al. Utility of the Doppler ultrasound parameter, resistive index, in renal transplant histopathology. Transplant Proc 2008; 40(1):104-106.
16. Parolini C, Noce A, Staffolani E, Giarrizzo GF, Costanzi S, Splendiani G. Renal resistive index and long-term outcome in chronic nephropathies. Radiology 2009; 252(3):888-896.
17. Helenon O, Melki P, Correas JM, Boyer JC, Moreau JF. Renovascular disease: Doppler ultrasound. Seminars in ultrasound, CT, and MR 1997; 18(2):136-146.
18. Tublin ME, Bude RO, Platt JF. Review. The resistive index in renal Doppler sonography: where do we stand? AJR Am J Roentgenol 2003; 180(4):885-892.
19. Colli A, Cocciolo M, Riva C, Martinez E. Abnormal renovascular impedance in patients with hepatic cirrhosis: detection with duplex US. Radiology 1993; 187(2):561-563.
20. Woods LL. Mechanisms of renal hemodynamic regulation in response to protein feeding. Kidney Inter 1993; 44(4):659-675.
21. Ratto E, Leoncini G, Viazzi F, Vaccaro V, Falqui V, Parodi A, Conti N, Tomolillo C, Deferrari G, Pontremoli R. Ambulatory arterial stiff ness index and renal abnormalities in primary hypertension. J Hypertens 2006; 24(10):2033-2038.
22. Sugiura T, Wada A. Resistive index predicts renal prognosis in chronic kidney disease: results of a 4-year follow-up. Clin Exp Nephrol 2011; 15(1):114-120.
23. Radermacher J, Ellis S, Haller H. Renal resistance index and progression of renal disease. Hypertension 2002; 39(2 Pt 2):699-703.
24. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59(7):574-580.
25. Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, Saito H, Yuki H, Kato S, Tomoike H. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2000; 161(4 Pt 1):1179-1184.
26. Hirota T, Suzuki E, Ito I, et al. Coronary artery calcification, arterial stiff ness and renal insufficiency associate with serum levels of tumor necrosis factor-alpha in Japanese type 2 diabetic patients. Diabetes Res Clin Pract 2008; 82(1):58-65
27. Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D. Tumor necrosis factor-alpha antagonists improve aortic stiff ness in patients with inflammatory arthropathies: a controlled study. Hypertension 2010; 55(2):333-338.
28. Sharkey RA, Mulloy EM, Kilgallen IA, O'Neill SJ. Renal functional reserve in patients with severe chronic obstructive pulmonary disease. Thorax 1997; 52(5):411-415.
29. Makino Y, Ogawa M, Ueda S, Hori J, Ohto M, Wakashin M, Akikusa B, Yamamoto S. Intrarenal arterial Doppler sonography in patients with various renal disease: correlation of resistive index with biopsy findings. Nihon Jinzo Gakkai Shi 1992; 34(2):207-212.
30. Lamb EJ, Webb MC, Simpson DE, Coakley AJ, Newman DJ, O'Riordan SE. Estimation of glomerular filtration rate in older patients with chronic renal insufficiency: is the modification of diet in renal disease formula an improvement? J Amer Geriatr Soc 2003; 51(7):1012-1017.
31. Du Bois D, Du Bois EF. Clinical calorimetry: tenth paper a formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17:863-871.
32. Coleta KD, Silveira LV, Lima DF, Rampinelli EA, Godoy I. Predictors of first-year survival in patients with advanced COPD treated using long-term oxygen therapy. Respir Med 2008; 102(4):512-518.
33. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part two. Amer J Respir Crit Care Med 1994; 150(4):1158-1168.
34. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med 2004; 351(13):1296-1305.
35. Ross R. Atherosclerosis-An inflammatory disease. New Engl J Med 1999; 340(2):115-126.
36. Iwamoto H, Yokoyama A, Kitahara Y, Ishikawa N, Haruta Y, Yamane K, Hattori N, Hara H, Kohno N. Airflow limitation in smokers is associated with subclinical atherosclerosis. Amer J Respir Crit Care Med 2009; 179(1):35-40.
37. Shlipak MG, Katz R, Kestenbaum B, Fried LF, Siscovick D, Sarnak MJ. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis 2009; 204(1):298-303.
38. Elsayed EF, Tighiouart H, Griffith J, Kurth T, Levey AS, Salem D, Sarnak MJ, Weiner DE. Cardiovascular disease and subsequent kidney disease. Arch Intern Med 2007; 167(11):1130-1136.
39. Mills NL, Miller JJ, Anand A, Robinson SD, Frazer GA, Anderson D, Breen L, Wilkinson IB, McEniery CM, Donaldson K, et al. Increased arterial stiff ness in patients with chronic obstructive pulmonary disease: A mechanism for increased cardiovascular risk. Thorax 2008; 63(4):306-311.
40. Sharkey RA, Mulloy EM, O'Neill SJ. Acute effects of hypoxaemia, hyperoxaemia and hypercapnia on renal blood flow in normal and renal transplant subjects. Euro Respir J: Off J Euro Soc Clin Respir Physiol 1998; 12(3):653-657.
41. Darmon M, Schortgen F, Leon R, Moutereau S, Mayaux J, Di Marco F, Devaquet J, Brun-Buisson C, Brochard L. Impact of mild hypoxemia on renal function and renal resistive index during mechanical ventilation. Intens Care Med 2009; 35(6):1031-1038.
42. Mendes ES, Campos MA, Wanner A. Airway blood flow reactivity in healthy smokers and in ex-smokers with or without COPD. Chest 2006; 129(4):893-898.
43. Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Amer J Epidemiol 2006; 164(3):263-271.
44. Rus HG, Niculescu F, Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1991; 89(2-3):247-254.
45. Ohta H, Wada H, Niwa T, Kirii H, Iwamoto N, Fujii H, Saito K, Sekikawa K, Seishima M. Disruption of tumor necrosis factoralpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 2005; 180(1):11-17.
46. Guo G, Morrissey J, McCracken R, Tolley T, Liapis H, Klahr S. Contributions of angiotensin II and tumor necrosis factoralpha to the development of renal fibrosis. Amer J Physiol Renal Physiol 2001; 280(5):F777-785.
47. Berni A, Ciani E, Bernetti M, Cecioni I, Berardino S, Poggesi L, Abbate R, Boddi M. Renal resistive index and low-grade inflammation in patients with essential hypertension. J Hum Hypertens 2011; 10:1-8.
48. Ozelsancak R, Torun D, Koc Z, Sezer S, Ozdemir FN, Niron EA. Relationship between renal resistive index and inflammation in untreated hypertensive patients. Int Heart J 2009; 50(6):753-761.
49. Raff U, Schwarz TK, Schmidt BM, Schneider MP, Schmieder RE. Renal resistive index-a valid tool to assess renal endothelial function in humans? Nephrology, Dialysis, Transplantation: official publication of the European Dialysis and Transplant Association -European Renal Association 2010; 25(6):1869-1874.
50. Petersen LJ, Petersen JR, Talleruphuus U, Ladefoged SD, Mehlsen J, Jensen HA. The pulsatility index and the resistive index in renal arteries. Associations with long-term progression in chronic renal failure. Nephrology, Dialysis, Transplantation: Official publication of the European Dialysis and Transplant Association -European Renal Association 1997; 12(7):1376-1380.
51. Colli A, Fraquelli M, Pometta R, Cocciolo M, Visentin S, Conte D. Renovascular impedance and esophageal varices in patients with Child-Pugh class A cirrhosis. Radiology 2001; 219(3):712-715.
52. Okon EB, Chung AW, Zhang H, Laher I, van Breemen C. Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes. Can J Physiol Pharmacol 2007; 85(5):562-567.
53. Casanova C, de Torres JP, Navarro J, Aguirre-Jaime A, Toledo P, Cordoba E, Baz R, Celli BR. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2010; 182(8):1004-1010.